LH EBITDA Growth
LabCorp · EBITDA Growth
LH EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported15.03%period ending
LH TTM EBITDA YoY % (-59.83% → 15.03%)
Year-over-year change
High-resolution chart · PNG
LH ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 15.0342% | |
| 13.9354% | |
| 11.1191% | |
| 14.423% | |
| 5.6305% | |
| 6.7386% | |
| 8.9504% | |
| 13.6073% | |
| 10.0702% | |
| -1.6468% | |
| -20.9575% | |
| -44.1344% | |
| -50.8193% | |
| -53.0517% | |
| -48.4965% | |
| -40.3137% | |
| -31.7959% | |
| -15.1718% | |
| 35.7601% | |
| 126.8289% | |
| 243.2262% | |
| 191.4132% | |
| 45.6143% | |
| 4.2382% | |
| -28.5707% | |
| -24.1991% | |
| 6.8149% | |
| -3.0759% | |
| -1.7133% | |
| 0.3481% | |
| 0.4414% | |
| 7.8545% | |
| 4.6315% | |
| 2.7724% | |
| 1.6149% | |
| 4.5078% | |
| 7.3658% | |
| 9.8786% | |
| 14.6687% | |
| 13.7711% | |
| 23.3517% | |
| 34.2334% | |
| 38.959% | |
| 33.3615% | |
| 21.607% | |
| 7.8584% | |
| -4.2666% | |
| -4.6841% | |
| -4.6346% | |
| -3.8% | |
| -2.0733% | |
| -4.0541% | |
| -3.5812% | |
| 0.1774% | |
| 6.7851% | |
| 10.5892% | |
| 10.5707% | |
| 3.558% | |
| -0.1093% | |
| 0.1882% | |
| -0.5053% | |
| 5.0447% | |
| 4.0784% | |
| 6.9057% | |
| 10.4009% | |
| 12.0968% | |
| 13.0168% | |
| 6.1766% | |
| 2.8494% | |
| -1.4442% | |
| 2.08% | |
| 7.7768% | |
| 11.9299% | |
| 16.2348% | |
| 16.3261% | |
| 14.9561% | |
| 12.5168% | |
| 11.1167% | |
| 8.4862% | |
| 7.5023% | |
| 7.1522% | |
| 6.4074% | |
| 6.587% | |
| 5.9331% | |
| 6.6331% | |
| 8.514% | |
| 9.7645% | |
| 16.7867% | |
| 20.6483% | |
| 20.6488% | |
| 21.0175% | |
| 15.1889% | |
| 12.1356% | |
| 14.8178% | |
| 17.536% | |
| 23.4357% | |
| 29.8746% | |
| 34.2112% | |
| 38.6651% | |
| 36.9586% |